Oxygen toxicity: Difference between revisions

No edit summary
No edit summary
Line 9: Line 9:
==Clinical Features==
==Clinical Features==
===Pulmonary===
===Pulmonary===
*Tracheobronchial irritation (initial manifestation) → pleuritic chest pain, dyspnea and coughing<ref name="Thomson">Thomson L, Paton J. Oxygen toxicity. Paediatr Respir Rev. 2014 Jun;15(2):120-3.</ref><ref name="Bitterman">Bitterman H. Bench-to-bedside review: Oxygen as a drug. Critical Care. 2009;13(1):205. doi:10.1186/cc7151.</ref>
*Tracheobronchial irritation (initial manifestation) → pleuritic [[chest pain]], [[dyspnea]] and [[cough]]ing<ref name="Thomson">Thomson L, Paton J. Oxygen toxicity. Paediatr Respir Rev. 2014 Jun;15(2):120-3.</ref><ref name="Bitterman">Bitterman H. Bench-to-bedside review: Oxygen as a drug. Critical Care. 2009;13(1):205. doi:10.1186/cc7151.</ref>
*Atelectasis
*Atelectasis
*Diffuse alveolar damage → [[Pulmonary edema]]/[[ARDS]]
*Diffuse alveolar damage → [[Pulmonary edema]]/[[ARDS]]


===Central nervous system===
===Central nervous system===
*Tunnel vision
*[[visual disturbances|Tunnel vision]]
*Tinnitus
*[[Tinnitus[[
*[[Nausea]]
*[[Nausea]]
*Facial twitching
*Facial twitching
*Irritability (personality changes, anxiety, confusion, etc.)
*Irritability (personality changes, anxiety, [[confusion]], etc.)
*[[Seizure]]
*[[Seizure]]


===Ocular===
===Ocular===
*Retinopathy of prematurity (retrolentar fibroplasia) - seen in premature infants
*Retinopathy of prematurity (retrolental fibroplasia) - seen in premature infants
*Hyperoxic myopia - seen in adults exposed to repeated toxic levels of oxygen<ref>Anderson B, Farmer JC. Hyperoxic myopia. Transactions of the American Ophthalmological Society. 1978;76:116-124.</ref>
*Hyperoxic myopia - seen in adults exposed to repeated toxic levels of oxygen<ref>Anderson B, Farmer JC. Hyperoxic myopia. Transactions of the American Ophthalmological Society. 1978;76:116-124.</ref>
**Resolves spontaneously over several weeks
**Resolves spontaneously over several weeks

Revision as of 21:38, 28 September 2019

Background

  • The harmful effects of breathing oxygen at higher partial pressures than normal
    • Partial pressure of O2 at sea level = 0.21 ATM
  • Toxicity based on both time of exposure and partial pressure of oxygen
    • Generally, FiO2 of 40% or less (0.40 ATM) can be tolerated indefinitely[1]
    • Most common in hyperbaric oxygen therapy, scuba divers and prolonged administration of normobaric supplemental oxygen
    • Pulmonary toxicity occurs sooner and at lower partial pressures than CNS toxicity[1], however there is no predictable pattern or sequence of symptoms for CNS toxicity (initial symptom may be seizure/coma)[2]

Clinical Features

Pulmonary

Central nervous system

Ocular

  • Retinopathy of prematurity (retrolental fibroplasia) - seen in premature infants
  • Hyperoxic myopia - seen in adults exposed to repeated toxic levels of oxygen[4]
    • Resolves spontaneously over several weeks

Differential Diagnosis

Diving Emergencies

Evaluation

  • Generally clinical

Management

  • Lower inhaled partial pressure of oxygen to as low as tolerated while maintaining tissue perfusion[5]

Disposition

  • Admit

See Also

External Links

References

  1. 1.0 1.1 Hedley-Whyte J. Pulmonary Oxygen Toxicity: Investigation and Mentoring. The Ulster Medical Journal. 2008;77(1):39-42.
  2. 2.0 2.1 Bitterman H. Bench-to-bedside review: Oxygen as a drug. Critical Care. 2009;13(1):205. doi:10.1186/cc7151.
  3. Thomson L, Paton J. Oxygen toxicity. Paediatr Respir Rev. 2014 Jun;15(2):120-3.
  4. Anderson B, Farmer JC. Hyperoxic myopia. Transactions of the American Ophthalmological Society. 1978;76:116-124.
  5. Deutschman, C. S., & Neligan, P. J. (2010). Evidence-based practice of critical care. Philadelphia, PA: Saunders/Elsevier.